Shanghai international consensus on diagnosis and comprehensive treatment of colorectal liver metastases (version 2019)-Reference-Cited by-同舟云学术

Shanghai international consensus on diagnosis and comprehensive treatment of colorectal liver metastases (version 2019)

Published:2020-06 Issue:6 Volume:46 Page:955-966
ISSN:0748-7983
Container-title:European Journal of Surgical Oncology
language:en
Short-container-title:European Journal of Surgical Oncology

Author:

Ren Li,Zhu Dexiang,Benson Al B.,Nordlinger Bernard,Koehne Claus-Henning,Delaney Conor P.,Kerr David^ORCID,Lenz Heinz-Josef,Fan Jia,Wang Jianping,Gu Jin,Li Jin,Shen Lin,Tsarkov Petrv^ORCID,Tejpar Sabine,Zheng Shu^ORCID,Zhang Suzhan,Gruenberger Thomas,Qin Xinyu,Wang Xishan,Zhang Zhongtao,Poston Graeme John,Xu Jianmin,Zhou Aiping,Parvaiz Amjad,Zhu Andrew,Eng Cathy,Lau Chi-wai,Song Chun,Tang Chung-ngai,Lynch Craig,Wan Desen,Loyer Evelyne,Aucejo Federico,Wang Feng,Chang George J.,Chen Gong,Yang Guang-zhong,Choi Gyu-Seog,Wieshmann Hulya,Tulina Inna,Oh Jae Hwan,Ngu James CY.,Wang Jaw-Yuan,Zhou Jian,Jin Jing,Liang Jin-Tung,Wang Jiping,Kwak Jung-myun,Okuda Junji,Lee Kang-Young,Ding Kefeng,Kuo Li-Jen,Ito Masaaki,Ohue Masayuki,Zeng Mengsu,Valente Michael,Miyoshi Norikatsu,Bianchi Paolo Pietro,Lan Ping,Xu Ruihua,Cai Sanjun,Kim Seon-Hahn,Wang Shan,Zeng Shan,Ng Simon SM.,Krishnamurthi Smitha,Fenwick Stephen,Akiyoshi Takashi,Liu Tianshu,Maughan Tim,Konishi Tsuyoshi,Law Wai Lun,Zhang Wei,Sun Weijing,Chen William Tzu-Liang,Wang Yajie,Wang Yi,Yuan Ying,Sun Yihong,Hou Yingyong,You YiQian Nancy,Lee Yoon-Suk,Yao Yunfeng,Liu Yunpeng,Kinugasa Yusuke,Zhang Zhen,Yan Zhiping,Pan Zhizhong,Xu Zhongfa,Zhou Zongguang

Funder

Clinical science and technology innovation project of Shanghai

Shanghai Science and Technology Committee Project

Publisher

Elsevier BV

Subject

Oncology,General Medicine,Surgery

Reference137 articles.

1. Treatment of metastatic disease of the liver: a skeptic's view;Foster;Semin Liver Dis,1984

2. Liver resection for colorectal metastases;Fong;J Clin Oncol,1997

3. FOLFOXIRI or FOLFOXIRI plus bevacizumab as first-line treatment of metastatic colorectal cancer: a propensity score-adjusted analysis from two randomized clinical trials;Cremolini;Ann Oncol,2016

4. First-line treatment of metastatic colorectal cancer: interpreting FIRE-3, PEAK, and CALGB/SWOG 80405;Elez;Curr Treat Options Oncol,2015

5. Bevacizumab plus mFOLFOX-6 or FOLFOXIRI in patients with initially unresectable liver metastases from colorectal cancer: the OLIVIA multinational randomised phase II trial;Gruenberger;Ann Oncol,2015

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. FASN promotes anoikis resistance in colorectal liver metastases through the ERK1/2 pathway;Biochemical and Biophysical Research Communications;2024-12

2. Neoadjuvant Statistical Algorithm to Predict Individual Risk of Relapse in Patients with Resected Liver Metastases from Colorectal Cancer;Biomedicines;2024-08-15

3. A pair of primary colorectal cancer-derived and corresponding synchronous liver metastasis-derived organoid cell lines;Aging;2024-02-24

4. Postoperative adjuvant chemotherapy is important for improving long‐term survival in patients with colorectal cancer liver metastases undergoing simultaneous resection;Journal of Gastroenterology and Hepatology;2024-02-07

5. Revolutionizing digestive system tumor organoids research: Exploring the potential of tumor organoids;Journal of Tissue Engineering;2024-01